Conduit Pharmaceuticals Inc. (CDT) Stock Analysis

Conduit Pharmaceuticals Inc. (CDT) is a publicly traded company in the HEALTHCARE sector. It trades at $0.85, carries a market capitalization of $4.35M. This page summarizes the public market data, fundamentals, and frequently asked questions for CDT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.85
• Market Cap: $4.35M
• EPS: $-1177.89
• 52-Week High: $610.00
• 52-Week Low: $0.79

Market Sentiment

Conduit Pharmaceuticals Inc. currently has a Neutral sentiment score of -0.06.

About Conduit Pharmaceuticals Inc.

None

GNG Research Analysis

GNG Research scores Conduit Pharmaceuticals Inc. (CDT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CDT.

Frequently Asked Questions

Does CDT pay dividends?

Conduit Pharmaceuticals Inc. (CDT) does not currently pay a regular dividend.

What is CDT's market cap?

Conduit Pharmaceuticals Inc. (CDT) has a market capitalization of $4.35M with a current stock price of $0.85.